Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Jiangsu Hengrui

From Wikipedia, the free encyclopedia
Chinese pharmaceutical company

Jiangsu Hengrui Pharmaceuticals Co. Ltd
Headquarters in Lianyungang
Company typePublic company
SSE:600276
CSI A50
SEHK: 1276
IndustryPharmaceuticals
Founded1997
HeadquartersLianyungang, Jiangsu, China
Area served
  • China
  • Global
Key people
Sun Piaoyang (chairman)
Number of employees
24,500 (2020)
Websitewww.hengrui.com

Jiangsu Hengrui Pharmaceuticals Company Ltd. (Chinese:江苏恒瑞医药股份有限公司), also known asJiangsu Hengrui (Chinese:恒瑞医药), is a Chinesepharmaceutical company that manufactures and distributes various types ofdrug packaging materials, cancer-treatingantineoplastics,cardiovascular medication,painkillers,antibiotics, and related products.[1][2] It is the largest listed pharmaceutical company in China.[3]

History

[edit]

Founded in 1970, Jiangsu Hengrui Pharmaceuticals was originally state-owned and called Lianyungang Pharmaceutical Factory (Chinese:连云港制药厂).[4][5] Headquartered inLianyungang, Jiangsu, it was established in its current form in 1977. The company was listed on theShanghai Stock Exchange in 2000[6] and now has locations in China, the United States, Germany, Switzerland, Japan, and Australia.

Research and development

[edit]

In 2020, Jiangsu Hengrui Pharmaceuticals set up research and development offices inPrinceton, New Jersey, and inBasel, Switzerland.[7][8] The Swiss-based Hengrui Europe Therapeutics AG also hosts the discoveryresearch and development units. Their focus is onprotein engineering and themRNA technology platform.

Since December 2020, Jiangsu Hengrui Pharmaceuticals has run clinical trials on anti-cancer drugs such as:

Trials were also performed in the fields ofmetabolic diseases (e.g.,type 2 diabetes[13]),autoimmune diseases (Interleukin-17 receptor blocker vanucizumab inpsoriasis),HIV treatment, andanalgesia.

See also

[edit]

References

[edit]
  1. ^Profile of Jiangsu Hengrui Medicine Company Limited
  2. ^"Search of: Hengrui - List Results - ClinicalTrials.gov".clinicaltrials.gov. Retrieved22 November 2020.
  3. ^China's pharmaceutical industry is poised for major growth
  4. ^"Sun Piaoyang".Forbes. Retrieved6 February 2021.
  5. ^"中国最牛"夫妻店"：日赚2亿，一人一家上市公司，掌管2500亿！".finance.sina.cn. 13 December 2020. Archived fromthe original on 6 February 2021. Retrieved6 February 2021.
  6. ^"Company Profile". Archived fromthe original on 28 October 2020. Retrieved8 January 2020.
  7. ^"Hengrui Medicine sets up clinical research and development in Basel".Basel Area Business & Innovation. Retrieved22 November 2020.
  8. ^"Entry in commercial registry "Handelsregisteramt des Kantons Basel-Stadt"".www.zefix.ch. Retrieved22 November 2020.
  9. ^"Search of: camrelizumab - List Results - ClinicalTrials.gov".clinicaltrials.gov. Retrieved30 December 2020.
  10. ^"Search of: SHR-3680 - List Results - ClinicalTrials.gov".clinicaltrials.gov. Retrieved30 December 2020.
  11. ^"Search of: SHR-3162 - List Results - ClinicalTrials.gov".clinicaltrials.gov. Retrieved30 December 2020.
  12. ^"Search of: SHR-3162 - List Results - ClinicalTrials.gov".clinicaltrials.gov. Retrieved30 December 2020.
  13. ^Jiangsu HengRui Medicine Co., Ltd. (9 December 2020)."Evaluation of the Efficacy and Safety of INS068 Injection and Insulin Degludec Subcutaneous Injection Once Daily in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With One or Two Oral Antidiabetics (A Randomized, Open-Label, Two-Arm, Treat-to-Target, Parallel Controlled Trial)".{{cite journal}}:Cite journal requires|journal= (help)

External links

[edit]
China Constituents ofHang Seng China 50 Index
China Constituents of theSSE 50 Index (as of 23 February 2024)
China Constituents of theFTSE China A50 Index
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jiangsu_Hengrui&oldid=1323701003"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp